Skip to main content
Livermore
Livermore
ZHEN

Glenview Trust Co

SEC CIK
0001691827
Latest filing
Aug 18, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Glenview Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
121,885
Value
$11.0M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of EW by Glenview Trust Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026121,885$11.0M0.2%−4,326−3.4%ReducedHolders
Q1 2026126,211$10.1M0.2%−5,219−4.0%ReducedHolders
Q4 2025131,430$11.2M0.2%−2,725−2.0%ReducedHolders
Q3 2025134,155$10.4M0.2%−16,401−10.9%ReducedHolders
Q2 2025150,556$11.8M0.2%−26,352−14.9%ReducedHolders
Q1 2025176,908$12.8M0.2%−180,654−50.5%ReducedHolders
Q4 2024357,562$26.5M0.5%−57,982−14.0%ReducedHolders
Q3 2024415,544$27.4M0.5%−11,215−2.6%ReducedHolders
Q2 2024426,759$39.4M0.8%+19,770+4.9%AddedHolders
Q1 2024406,989$38.9M0.8%+20,266+5.2%AddedHolders
Q4 2023386,723$29.5M0.7%−3,959−1.0%ReducedHolders
Q3 2023390,682$27.1M0.7%+29,436+8.1%AddedHolders
Q2 2023361,246$34.1M0.9%+19,424+5.7%AddedHolders
Q1 2023341,822$28.3M0.8%+22,017+6.9%AddedHolders
Q4 2022319,805$23.9M0.8%+148,341+86.5%AddedHolders
Q3 2022171,464$14.2M0.5%−5,900−3.3%ReducedHolders
Q2 2022177,364$16.9M0.6%−16,233−8.4%ReducedHolders
Q1 2022193,597$22.8M0.7%−33,156−14.6%ReducedHolders
Q4 2021226,753$29.4M1.0%−35,749−13.6%ReducedHolders
Q3 2021262,502$29.7M1.1%−13,430−4.9%ReducedHolders
Q2 2021275,932$28.6M1.1%+12,243+4.6%AddedHolders
Q1 2021263,689$22.1M0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.